Pharma giant AstraZeneca has pumped $3.5 billion (€3.4 billion) into an Irish subsidiary as it moves ahead with a new manufacturing facility in Dublin, due to be completed in 2026. Documents recently filed with the Companies Registration Office show AstraZeneca putting $800 million into a newly created Irish subsidiary at the end of last year. It is the latest cash injection by its parent into the unit, AstraZeneca Ireland Limited, bringing the total to $3.5 billion to date. AstraZeneca Ireland Limited was registered in January 2023 to manage a new drug manufacturing facility in Dublin, which is currently under construction,…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .